Antiseptic [EPC]

Antiseptic [EPC] was reported 4295 times

Drugs of the Antiseptic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 AQUEOUS FIBRIN 29 0.5686
1 CSF SHUNT REMOVAL 3 0.3750
2 TOXIC ANTERIOR SEGMENT SYNDROME 283 0.2633
3 HEPATIC ENZYME 28 0.2029
4 ANTERIOR CHAMBER FIBRIN 24 0.1860
5 POLYGLANDULAR DISORDER 11 0.1642
6 TONSILLAR ULCER 23 0.1608
7 FIBRIN 6 0.1429
8 BACTERIAL ENDOPHTHALMITIS 31 0.1235
9 HYPOPYON 85 0.1035
10 FOETAL NON-STRESS TEST ABNORMAL 6 0.1000
11 PAROPHTHALMIA 20 0.0855
12 PSEUDOENDOPHTHALMITIS 8 0.0808
13 ANTERIOR CHAMBER CELL 52 0.0731
14 ENDOPHTHALMITIS 427 0.0721
15 ANAEMIA FOLATE DEFICIENCY 11 0.0595
16 RETINAL FIBROSIS 4 0.0580
17 RETINAL CYST 9 0.0552
18 IODINE ALLERGY 17 0.0515
19 EYE INFECTION INTRAOCULAR 4 0.0513
20 DELAYED DELIVERY 7 0.0504
21 BALANITIS CANDIDA 6 0.0492
22 ANTERIOR CHAMBER DISORDER 11 0.0478
23 LOWER RESPIRATORY TRACT INFECTION VIRAL 23 0.0467
24 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 8 0.0462
25 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 8 0.0442
26 CANDIDA ENDOPHTHALMITIS 5 0.0417
27 HAEMORRHAGIC NECROTIC PANCREATITIS 3 0.0417
28 NON-INFECTIOUS ENDOPHTHALMITIS 35 0.0417
29 RETINOPATHY OF PREMATURITY 21 0.0387
30 VITRITIS 68 0.0378
31 CORNEAL INFILTRATES 11 0.0361
32 POSTOPERATIVE INFECTION 17 0.0356
33 VITREAL CELLS 7 0.0355
34 RETINAL ANEURYSM 7 0.0354
35 CORNEAL OEDEMA 78 0.0353
36 VITREOUS DEGENERATION 5 0.0340
37 CUTIS LAXA 9 0.0336
38 CORNEAL EPITHELIUM DEFECT 19 0.0335
39 VITREOUS HAZE 5 0.0329
40 CATARACT NUCLEAR 21 0.0324
41 RETINAL DRUSEN 5 0.0314
42 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 11 0.0313
43 RETINOGRAM ABNORMAL 8 0.0301
44 CATARACT OPERATION COMPLICATION 15 0.0298
45 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 25 0.0291
46 EYE NAEVUS 3 0.0278
47 PUNCTATE KERATITIS 24 0.0276
48 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 32 0.0263
49 CONJUNCTIVAL OEDEMA 26 0.0256
50 BILE ACIDS INCREASED 4 0.0252
51 RETINAL SCAR 11 0.0240
52 RETINAL OCCLUSIVE VASCULITIS 5 0.0237
53 HYPOCHOLESTEROLAEMIA 7 0.0230
54 VITREOUS DISORDER 11 0.0224
55 ANTERIOR CHAMBER INFLAMMATION 13 0.0224
56 FLAT ANTERIOR CHAMBER OF EYE 4 0.0223
57 RETINAL PIGMENT EPITHELIAL TEAR 15 0.0223
58 NAIL BED INFLAMMATION 7 0.0223
59 MACULAR SCAR 4 0.0212
60 DISORDER OF ORBIT 3 0.0210
61 ONYCHOMADESIS 86 0.0210
62 SUBRETINAL FIBROSIS 4 0.0207
63 CATARACT CORTICAL 3 0.0203
64 RHEUMATIC FEVER 87 0.0202
65 LIP ULCERATION 23 0.0199
66 VISUAL ACUITY REDUCED TRANSIENTLY 6 0.0196
67 CORNEAL ABRASION 25 0.0186
68 EYE OPERATION COMPLICATION 3 0.0182
69 DIABETIC RETINAL OEDEMA 9 0.0179
70 ANTERIOR CHAMBER FLARE 4 0.0172
71 ONYCHOMYCOSIS 73 0.0169
72 MACULAR FIBROSIS 11 0.0163
73 EPIRETINAL MEMBRANE 4 0.0156
74 POSTERIOR CAPSULE OPACIFICATION 5 0.0152
75 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 8 0.0149
76 FACET JOINT SYNDROME 46 0.0148
77 HYPOPARATHYROIDISM 11 0.0146
78 HYPOTONY OF EYE 6 0.0145
79 VITREOUS OPACITIES 12 0.0145
80 INTRAOCULAR LENS IMPLANT 7 0.0143
81 CORNEAL INFECTION 3 0.0141
82 CHRONIC HEPATITIS 11 0.0138
83 SKIN CANDIDA 7 0.0137
84 VITREOUS DETACHMENT 29 0.0137
85 HYPHAEMA 7 0.0135
86 CORNEAL OPACITY 18 0.0134
87 METAMORPHOPSIA 24 0.0132
88 CAUSTIC INJURY 4 0.0128
89 EYE INFECTION BACTERIAL 7 0.0128
90 VITREOUS HAEMORRHAGE 34 0.0124
91 CHOROIDAL NEOVASCULARISATION 10 0.0119
92 RETINAL EXUDATES 11 0.0119
93 ENTEROCUTANEOUS FISTULA 10 0.0116
94 OCULAR TOXICITY 12 0.0115
95 MATERNAL EXPOSURE DURING DELIVERY 11 0.0115
96 C-REACTIVE PROTEIN ABNORMAL 71 0.0112
97 PERIPHERAL VENOUS DISEASE 44 0.0112
98 BURNS FIRST DEGREE 3 0.0107
99 RETINAL INJURY 8 0.0105
100 EYE INFECTION STAPHYLOCOCCAL 3 0.0105
101 VASOCONSTRICTION 9 0.0105
102 NASAL MUCOSAL DISORDER 6 0.0104
103 RETINAL OEDEMA 19 0.0102
104 ECTHYMA 4 0.0101
105 PEMPHIGUS 122 0.0099
106 EYE ABSCESS 3 0.0099
107 OCULAR HYPERTENSION 18 0.0095
108 PRODUCT CONTAMINATION MICROBIAL 11 0.0095
109 LENTICULAR OPACITIES 4 0.0094
110 EXOPHTHALMOS 19 0.0090
111 DUODENAL ULCER PERFORATION 65 0.0090
112 BLEPHAROSPASM 54 0.0088
113 RETINAL VASCULAR DISORDER 5 0.0088
114 ENDOCRINE DISORDER 11 0.0087
115 CYSTOID MACULAR OEDEMA 16 0.0087
116 EYE SYMPTOM 3 0.0087
117 EYE OEDEMA 21 0.0087
118 KERATIC PRECIPITATES 4 0.0086
119 CATHETER REMOVAL 3 0.0086
120 RETINAL ISCHAEMIA 5 0.0084
121 EXANTHEM 3 0.0083
122 POST PROCEDURAL DISCOMFORT 17 0.0083
123 OPEN ANGLE GLAUCOMA 5 0.0083
124 BREAST CANCER STAGE III 52 0.0082
125 GLARE 4 0.0080
126 PERICARDITIS 131 0.0080
127 OLIGURIA 48 0.0078
128 VITREOUS FLOATERS 74 0.0077
129 LUPUS VULGARIS 9 0.0077
130 CORNEAL EROSION 4 0.0076
131 MACULAR OEDEMA 42 0.0076
132 TONGUE ERYTHEMA 6 0.0075
133 PRESBYOPIA 4 0.0074
134 RETINAL DISORDER 19 0.0074
135 OVERLAP SYNDROME 5 0.0073
136 EYE INFLAMMATION 68 0.0073
137 NAIL DYSTROPHY 4 0.0073
138 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 51 0.0073
139 TWIN PREGNANCY 6 0.0072
140 CULTURE POSITIVE 6 0.0072
141 CHEMICAL BURN 8 0.0071
142 IRIDOCYCLITIS 22 0.0071
143 EYELID INFECTION 3 0.0069
144 CELLULITIS ORBITAL 4 0.0069
145 ALLERGY TEST POSITIVE 3 0.0069
146 BRAIN STEM SYNDROME 5 0.0067
147 DEEP VEIN THROMBOSIS POSTOPERATIVE 13 0.0067
148 FOLLICULITIS 68 0.0067
149 BANKRUPTCY 3 0.0067
150 CATARACT SUBCAPSULAR 4 0.0066
151 CAUDA EQUINA SYNDROME 5 0.0066
152 STRESS URINARY INCONTINENCE 7 0.0065
153 SKIN TEST POSITIVE 6 0.0065
154 RETINAL HAEMORRHAGE 45 0.0064
155 SYNOVITIS 112 0.0063
156 MUSCLE INJURY 49 0.0060
157 STREPTOCOCCAL SEPSIS 7 0.0059
158 ARACHNOIDITIS 4 0.0059
159 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 8 0.0059
160 SUBRETINAL FLUID 6 0.0058
161 AMAUROSIS FUGAX 6 0.0057
162 FOREIGN BODY SENSATION IN EYES 35 0.0057
163 RETINAL DEGENERATION 7 0.0057
164 AMNIOTIC CAVITY INFECTION 4 0.0056
165 HYPERCHOLESTEROLAEMIA 53 0.0056
166 CHOROIDAL DETACHMENT 3 0.0055
167 RETINITIS 9 0.0055
168 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 5 0.0054
169 FINGER DEFORMITY 26 0.0054
170 CONJUNCTIVAL HYPERAEMIA 19 0.0054
171 VITILIGO 12 0.0053
172 HELICOBACTER INFECTION 53 0.0053
173 INTRAOCULAR PRESSURE INCREASED 66 0.0052
174 LIP DRY 46 0.0052
175 PSEUDOMONAL SEPSIS 9 0.0052
176 NAIL DISORDER 44 0.0051
177 EMBOLIA CUTIS MEDICAMENTOSA 4 0.0051
178 GIANT CELL ARTERITIS 4 0.0050
179 VISUAL ACUITY REDUCED 165 0.0050
180 CORNEAL PERFORATION 3 0.0049
181 INFUSION SITE REACTION 14 0.0049
182 CONJUNCTIVAL HAEMORRHAGE 18 0.0048
183 WOUND INFECTION 51 0.0048
184 LIVE BIRTH 39 0.0047
185 WOUND 130 0.0047
186 CHORIORETINITIS 3 0.0047
187 TONSILLITIS 24 0.0047
188 UTERINE PROLAPSE 5 0.0047
189 PILOERECTION 5 0.0046
190 BLEPHARITIS 18 0.0046
191 BURSITIS 55 0.0046
192 DRY AGE-RELATED MACULAR DEGENERATION 5 0.0046
193 HAND DEFORMITY 59 0.0046
194 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 3 0.0046
195 PUPILLARY REFLEX IMPAIRED 8 0.0044
196 FUSARIUM INFECTION 3 0.0044
197 DERMATITIS EXFOLIATIVE GENERALISED 15 0.0044
198 CERUMEN IMPACTION 4 0.0044
199 CORNEAL DISORDER 9 0.0042
200 PCO2 DECREASED 4 0.0042
201 EPIDERMAL NECROSIS 4 0.0041
202 DISLOCATION OF VERTEBRA 9 0.0041
203 BLINDNESS UNILATERAL 56 0.0040
204 CHLAMYDIAL INFECTION 3 0.0040
205 MACULOPATHY 14 0.0040
206 TYPE 2 DIABETES MELLITUS 132 0.0040
207 MACULAR HOLE 5 0.0038
208 JOINT RANGE OF MOTION DECREASED 50 0.0038
209 CARDIOVASCULAR INSUFFICIENCY 6 0.0037
210 RETINAL TEAR 9 0.0037
211 ULCERATIVE KERATITIS 10 0.0037
212 GRIP STRENGTH DECREASED 32 0.0037
213 KERATITIS 11 0.0037
214 EYE PAIN 201 0.0037
215 STAPHYLOCOCCAL SEPSIS 18 0.0037
216 PORPHYRIA ACUTE 5 0.0037
217 EYELID OEDEMA 41 0.0035
218 C-REACTIVE PROTEIN INCREASED 127 0.0035
219 DERMATITIS BULLOUS 25 0.0035
220 SYSTEMIC LUPUS ERYTHEMATOSUS 122 0.0035
221 CATHETER SITE PRURITUS 3 0.0035
222 CONJUNCTIVITIS ALLERGIC 5 0.0035
223 MULTIPLE USE OF SINGLE-USE PRODUCT 19 0.0035
224 X-RAY ABNORMAL 6 0.0034
225 CATHETER MANAGEMENT 3 0.0034
226 C-REACTIVE PROTEIN 3 0.0033
227 PREMATURE RUPTURE OF MEMBRANES 8 0.0033
228 STAPHYLOCOCCUS TEST POSITIVE 7 0.0033
229 ORAL MUCOSAL ERUPTION 5 0.0033
230 TOXIC SKIN ERUPTION 33 0.0033
231 PSORIATIC ARTHROPATHY 131 0.0033
232 RETINAL ARTERY OCCLUSION 8 0.0032
233 PHOTOPSIA 20 0.0032
234 OCULAR DISCOMFORT 34 0.0032
235 ANGLE CLOSURE GLAUCOMA 8 0.0032
236 COR PULMONALE 3 0.0032
237 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 20 0.0031
238 FIBROMYALGIA 75 0.0031
239 PSYCHIATRIC DECOMPENSATION 6 0.0031
240 PROCEDURAL HAEMORRHAGE 12 0.0031
241 GLOSSODYNIA 68 0.0031
242 PURULENT DISCHARGE 13 0.0031
243 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 6 0.0030
244 NORMAL NEWBORN 16 0.0030
245 OSTEOLYSIS 6 0.0030
246 BENIGN BREAST NEOPLASM 3 0.0030
247 CARPAL TUNNEL DECOMPRESSION 3 0.0029
248 NECROTISING FASCIITIS 10 0.0029
249 BURNS THIRD DEGREE 3 0.0029
250 RETINAL DETACHMENT 26 0.0029
251 DERMATITIS CONTACT 32 0.0029
252 UVEITIS 38 0.0029
253 NORMOCYTIC ANAEMIA 4 0.0028
254 OBESITY 44 0.0028
255 CATHETER SITE DISCHARGE 3 0.0028
256 RASH VESICULAR 13 0.0027
257 CONTRAINDICATED PRODUCT ADMINISTERED 81 0.0027
258 CONJUNCTIVITIS 49 0.0027
259 ASTIGMATISM 4 0.0027
260 EYELID PAIN 5 0.0026
261 POST PROCEDURAL COMPLICATION 49 0.0026
262 HYPERAEMIA 5 0.0026
263 EPILEPSY 77 0.0026
264 GENITAL HAEMORRHAGE 32 0.0025
265 ANAPHYLACTIC SHOCK 63 0.0025
266 TASTE DISORDER 49 0.0025
267 ANAPHYLACTOID REACTION 10 0.0025
268 DYSFUNCTIONAL UTERINE BLEEDING 3 0.0025
269 PENIS DISORDER 6 0.0024
270 PRODUCT LABEL CONFUSION 14 0.0024
271 CHRONIC SINUSITIS 9 0.0024
272 CATHETER SITE ERYTHEMA 5 0.0024
273 IMPAIRED SELF-CARE 5 0.0024
274 STRIDOR 7 0.0024
275 CATHETER SITE PAIN 6 0.0024
276 LIVER INJURY 57 0.0024
277 DIABETIC RETINOPATHY 8 0.0024
278 ADNEXA UTERI PAIN 3 0.0024
279 PUSTULAR PSORIASIS 8 0.0024
280 PARONYCHIA 10 0.0023
281 BLOOD CHLORIDE DECREASED 6 0.0023
282 ORAL INFECTION 9 0.0023
283 ANAESTHETIC COMPLICATION 6 0.0023
284 SWOLLEN JOINT COUNT INCREASED 7 0.0023
285 HYPOALBUMINAEMIA 17 0.0023
286 URINARY TRACT DISORDER 10 0.0023
287 ANGIONEUROTIC OEDEMA 6 0.0023
288 BACK INJURY 24 0.0022
289 BLINDNESS TRANSIENT 16 0.0022
290 BLINDNESS 86 0.0021
291 ULCER HAEMORRHAGE 14 0.0021
292 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 16 0.0021
293 WOUND SECRETION 8 0.0021
294 EYELID IRRITATION 5 0.0021
295 IRRITABLE BOWEL SYNDROME 43 0.0020
296 IMPAIRED HEALING 66 0.0020
297 VASODILATATION 5 0.0020
298 PATHOGEN RESISTANCE 18 0.0020
299 IRITIS 6 0.0020
300 DRUG HYPERSENSITIVITY 383 0.0020
301 EYE IRRITATION 109 0.0020
302 CHEMICAL BURN OF SKIN 5 0.0020
303 EYE ALLERGY 3 0.0020
304 MOUTH ULCERATION 41 0.0020
305 BACTERIAL VAGINOSIS 3 0.0020
306 FEBRILE BONE MARROW APLASIA 8 0.0019
307 PERSONALITY DISORDER 5 0.0019
308 MYOSITIS 17 0.0019
309 INFLAMMATION 96 0.0019
310 EYE HAEMORRHAGE 25 0.0019
311 EYE DISCHARGE 19 0.0019
312 LYMPHOPENIA 26 0.0019
313 ASTHENOPIA 10 0.0019
314 POOR QUALITY DRUG ADMINISTERED 12 0.0019
315 PHOTOPHOBIA 34 0.0018
316 BACTERIAL TEST POSITIVE 4 0.0018
317 CHRONIC GASTRITIS 4 0.0018
318 LACRIMATION INCREASED 53 0.0018
319 VASCULAR DEVICE INFECTION 8 0.0018
320 ENTERITIS INFECTIOUS 3 0.0018
321 TOXIC EPIDERMAL NECROLYSIS 26 0.0017
322 TYPE I HYPERSENSITIVITY 6 0.0017
323 BURNS SECOND DEGREE 3 0.0017
324 OCULAR HYPERAEMIA 80 0.0017
325 THERAPEUTIC PRODUCT EFFECT DECREASED 76 0.0017
326 BLISTER 94 0.0017
327 INFUSION RELATED REACTION 110 0.0017
328 EYE INJURY 5 0.0017
329 ADVERSE REACTION 22 0.0017
330 ANAPHYLACTIC REACTION 91 0.0017
331 PULSE ABNORMAL 4 0.0017
332 ABNORMAL SENSATION IN EYE 7 0.0017
333 MEDICAL DEVICE DISCOMFORT 5 0.0016
334 CATHETER SITE HAEMORRHAGE 4 0.0016
335 SKIN INFECTION 18 0.0016
336 NIGHT SWEATS 51 0.0016
337 DERMATITIS EXFOLIATIVE 8 0.0016
338 IRON DEFICIENCY 7 0.0016
339 STOMATITIS 95 0.0016
340 RHEUMATOID FACTOR POSITIVE 9 0.0016
341 GENERALISED ERYTHEMA 9 0.0016
342 COELIAC DISEASE 15 0.0015
343 DEAFNESS NEUROSENSORY 5 0.0015
344 CONCOMITANT DISEASE PROGRESSION 3 0.0015
345 CANDIDA INFECTION 25 0.0015
346 SUDDEN DEATH 16 0.0015
347 VAGINAL DISCHARGE 15 0.0015
348 PROCEDURAL PAIN 41 0.0015
349 ORAL CANDIDIASIS 19 0.0015
350 WOUND COMPLICATION 5 0.0015
351 KIDNEY TRANSPLANT REJECTION 7 0.0015
352 OSTEOARTHRITIS 61 0.0015
353 STREPTOCOCCAL INFECTION 8 0.0015
354 TONGUE DISCOMFORT 6 0.0014
355 EMBEDDED DEVICE 14 0.0014
356 FOETAL DISTRESS SYNDROME 3 0.0014
357 UNDERDOSE 103 0.0014
358 UTERINE HAEMORRHAGE 6 0.0014
359 SWELLING 130 0.0014
360 CERVICAL DYSPLASIA 3 0.0014
361 RASH PUSTULAR 10 0.0014
362 METASTASES TO LYMPH NODES 9 0.0014
363 HAEMATURIA 46 0.0014
364 ILL-DEFINED DISORDER 81 0.0014
365 GAIT INABILITY 44 0.0013
366 DYSCHEZIA 4 0.0013
367 PAPILLOEDEMA 6 0.0013
368 SWELLING OF EYELID 8 0.0013
369 ERYTHEMA OF EYELID 7 0.0013
370 SLEEP DISORDER 91 0.0013
371 LARYNGITIS 14 0.0013
372 DISCOMFORT 78 0.0013
373 APPLICATION SITE REACTION 9 0.0013
374 DRUG-INDUCED LIVER INJURY 39 0.0013
375 ENTEROCOCCAL INFECTION 6 0.0013
376 DEVICE RELATED INFECTION 19 0.0012
377 GLOMERULONEPHRITIS 3 0.0012
378 DERMAL CYST 3 0.0012
379 HYPERURICAEMIA 5 0.0012
380 RASH MACULO-PAPULAR 27 0.0012
381 VISION BLURRED 166 0.0012
382 BLOOD CHOLESTEROL INCREASED 56 0.0012
383 LOWER RESPIRATORY TRACT INFECTION 54 0.0012
384 POSTOPERATIVE WOUND INFECTION 8 0.0012
385 LIP OEDEMA 5 0.0012
386 MACULAR DEGENERATION 14 0.0012
387 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 83 0.0012
388 CANCER PAIN 3 0.0012
389 RHEUMATOID ARTHRITIS 132 0.0012
390 GASTROENTERITIS 17 0.0012
391 INJECTION SITE REACTION 80 0.0012
392 VARICOSE VEIN 6 0.0012
393 COMPARTMENT SYNDROME 3 0.0012
394 EOSINOPHILIA 20 0.0012
395 MELANOCYTIC NAEVUS 5 0.0012
396 SKIN REACTION 16 0.0012
397 SCIATICA 18 0.0011
398 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19 0.0011
399 VISUAL IMPAIRMENT 139 0.0011
400 BONE EROSION 4 0.0011
401 THERMAL BURN 8 0.0011
402 WHEEZING 66 0.0011
403 RENAL FAILURE ACUTE 48 0.0011
404 SPONDYLITIS 4 0.0011
405 UTERINE LEIOMYOMA 8 0.0011
406 ROSACEA 5 0.0011
407 MATERNAL EXPOSURE TIMING UNSPECIFIED 4 0.0011
408 TREATMENT FAILURE 88 0.0011
409 CATHETER SITE INFECTION 4 0.0011
410 ACUTE PULMONARY OEDEMA 6 0.0011
411 LUNG DISORDER 52 0.0011
412 STAPHYLOCOCCAL INFECTION 35 0.0011
413 GENERALISED OEDEMA 13 0.0011
414 SWOLLEN TONGUE 33 0.0011
415 PULMONARY FIBROSIS 20 0.0011
416 INTENTIONAL PRODUCT USE ISSUE 92 0.0011
417 BREAST CANCER STAGE IV 3 0.0011
418 SUBCUTANEOUS ABSCESS 5 0.0011
419 LIVER FUNCTION TEST INCREASED 22 0.0010
420 CATARACT 61 0.0010
421 EYE SWELLING 38 0.0010
422 ABDOMINAL PAIN LOWER 26 0.0010
423 COMPLICATION OF DEVICE INSERTION 19 0.0010
424 ARTHROPATHY 57 0.0010
425 RENAL TUBULAR NECROSIS 10 0.0010
426 OEDEMA 55 0.0010
427 LUPUS-LIKE SYNDROME 9 0.0010
428 BONE MARROW DISORDER 3 0.0010
429 SEPTIC SHOCK 43 0.0010
430 RED BLOOD CELL SEDIMENTATION RATE INCREASED 11 0.0010
431 BLOOD CULTURE POSITIVE 3 0.0010
432 PELVIC PAIN 18 0.0010
433 LARYNGEAL OEDEMA 6 0.0010
434 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
435 EYE PRURITUS 32 0.0010
436 VISUAL FIELD DEFECT 7 0.0010
437 ERYTHEMA MULTIFORME 9 0.0010
438 SKIN NECROSIS 5 0.0010
439 GASTROOESOPHAGEAL REFLUX DISEASE 77 0.0010
440 SKIN LESION 26 0.0010
441 BLOOD LACTIC ACID INCREASED 5 0.0010
442 HORDEOLUM 4 0.0010
443 MATERNAL EXPOSURE DURING PREGNANCY 83 0.0010
444 AUTOIMMUNE DISORDER 9 0.0010
445 ABSCESS LIMB 4 0.0010
446 HYPOGAMMAGLOBULINAEMIA 6 0.0009
447 ANAL ABSCESS 5 0.0009
448 DRUG INTOLERANCE 89 0.0009
449 APHTHOUS ULCER 7 0.0009
450 LYMPHOCYTE COUNT DECREASED 16 0.0009
451 RHINITIS ALLERGIC 4 0.0009
452 ILEUS PARALYTIC 4 0.0009
453 OVARIAN CYST 9 0.0009
454 EYE INFECTION 10 0.0009
455 HYPERSENSITIVITY 165 0.0009
456 DERMATITIS ALLERGIC 11 0.0009
457 LOW BIRTH WEIGHT BABY 7 0.0009
458 GRANULOCYTOPENIA 5 0.0009
459 LOCALISED OEDEMA 4 0.0009
460 POST PROCEDURAL INFECTION 7 0.0009
461 DEFAECATION URGENCY 6 0.0009
462 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
463 NEPHROGENIC ANAEMIA 4 0.0009
464 ASCITES 25 0.0009
465 HYPOCALCAEMIA 16 0.0009
466 CONFUSIONAL STATE 137 0.0009
467 DRY MOUTH 67 0.0008
468 HYPOXIA 29 0.0008
469 BLOOD PRESSURE INADEQUATELY CONTROLLED 5 0.0008
470 GANGRENE 5 0.0008
471 MUSCULOSKELETAL PAIN 42 0.0008
472 VULVOVAGINAL PRURITUS 4 0.0008
473 DYSLIPIDAEMIA 4 0.0008
474 HYPOKALAEMIA 36 0.0008
475 URTICARIA 130 0.0008
476 PROCEDURAL COMPLICATION 6 0.0008
477 BRONCHOSPASM 11 0.0008
478 EXOSTOSIS 7 0.0008
479 HAEMORRHAGIC STROKE 6 0.0008
480 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
481 FUNGAL SKIN INFECTION 3 0.0008
482 MIGRAINE 71 0.0008
483 GINGIVITIS 4 0.0008
484 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
485 CANDIDIASIS 3 0.0007
486 ARTHRITIS BACTERIAL 3 0.0007
487 LOWER LIMB FRACTURE 14 0.0007
488 EYE MOVEMENT DISORDER 5 0.0007
489 ECCHYMOSIS 5 0.0007
490 RASH ERYTHEMATOUS 34 0.0007
491 HYPERKERATOSIS 4 0.0007
492 SKIN TOXICITY 4 0.0007
493 SPINAL COMPRESSION FRACTURE 6 0.0007
494 PSEUDOMONAS INFECTION 6 0.0007
495 FACE OEDEMA 12 0.0007
496 SINUS TACHYCARDIA 10 0.0007
497 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 18 0.0007
498 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
499 PREMATURE LABOUR 4 0.0007
500 BACTERIAL INFECTION 13 0.0007
501 HEPATIC CIRRHOSIS 13 0.0007
502 ABDOMINAL DISCOMFORT 115 0.0007
503 RASH GENERALISED 18 0.0007
504 URINE OUTPUT DECREASED 6 0.0007
505 GINGIVAL SWELLING 3 0.0007
506 ORAL DISORDER 5 0.0007
507 MELAENA 15 0.0007
508 PRODUCT USE IN UNAPPROVED INDICATION 166 0.0007
509 ODYNOPHAGIA 4 0.0007
510 DERMATITIS 14 0.0007
511 CATARACT OPERATION 4 0.0007
512 DEVICE DEPLOYMENT ISSUE 8 0.0007
513 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
514 JOINT SWELLING 79 0.0007
515 DIPLOPIA 17 0.0007
516 DYSPAREUNIA 3 0.0007
517 GENERAL PHYSICAL HEALTH DETERIORATION 75 0.0007
518 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0007
519 FEBRILE NEUTROPENIA 43 0.0007
520 BLOOD SODIUM DECREASED 12 0.0006
521 RASH 275 0.0006
522 STEVENS-JOHNSON SYNDROME 14 0.0006
523 PARAESTHESIA ORAL 9 0.0006
524 FISTULA 7 0.0006
525 FAECAL INCONTINENCE 3 0.0006
526 POLYURIA 5 0.0006
527 APPLICATION SITE BURN 3 0.0006
528 WALKING AID USER 4 0.0006
529 MENORRHAGIA 12 0.0006
530 HEPATIC ENZYME ABNORMAL 3 0.0006
531 ANEURYSM 3 0.0006
532 DEVICE DISLOCATION 26 0.0006
533 MENINGITIS 4 0.0006
534 HYPOAESTHESIA ORAL 9 0.0006
535 ERYSIPELAS 3 0.0006
536 PRODUCT USE ISSUE 110 0.0006
537 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
538 UTERINE PERFORATION 5 0.0006
539 DRUG RESISTANCE 15 0.0006
540 INJURY 41 0.0006
541 NOCTURIA 7 0.0006
542 RASH MACULAR 20 0.0006
543 GLAUCOMA 11 0.0006
544 MASS 8 0.0006
545 PRESCRIBED OVERDOSE 11 0.0006
546 RECALLED PRODUCT ADMINISTERED 5 0.0006
547 EAR PAIN 11 0.0006
548 ABSCESS 9 0.0006
549 PHARYNGITIS 7 0.0006
550 MUSCULOSKELETAL STIFFNESS 49 0.0006
551 OFF LABEL USE 483 0.0006
552 BRUXISM 3 0.0006
553 SEPSIS 62 0.0006
554 CELLULITIS 28 0.0006
555 CHEILITIS 3 0.0006
556 BRAIN OEDEMA 7 0.0006
557 WRONG DRUG ADMINISTERED 5 0.0006
558 RESPIRATORY DISTRESS 15 0.0006
559 APPENDICITIS 5 0.0005
560 GASTRIC ULCER HAEMORRHAGE 3 0.0005
561 DRY EYE 26 0.0005
562 HYDRONEPHROSIS 4 0.0005
563 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
564 CIRCULATORY COLLAPSE 9 0.0005
565 ANGIOEDEMA 23 0.0005
566 DEVICE USE ISSUE 9 0.0005
567 EYE DISORDER 17 0.0005
568 NEUTROPHIL COUNT DECREASED 21 0.0005
569 ATELECTASIS 5 0.0005
570 CONGENITAL ANOMALY 4 0.0005
571 PRODUCT QUALITY ISSUE 69 0.0005
572 HEAD DISCOMFORT 9 0.0005
573 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
574 BACTERAEMIA 6 0.0005
575 HEPATITIS 13 0.0005
576 LUNG INFECTION 8 0.0005
577 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
578 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
579 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
580 PRESCRIBED UNDERDOSE 10 0.0005
581 HYPOAESTHESIA 75 0.0005
582 APPLICATION SITE PAIN 11 0.0005
583 CARDIO-RESPIRATORY ARREST 21 0.0005
584 EXPOSURE DURING PREGNANCY 31 0.0005
585 ECZEMA 25 0.0005
586 RHINITIS 4 0.0005
587 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
588 DERMATITIS ACNEIFORM 3 0.0005
589 HYPERTENSION 105 0.0005
590 SCHIZOPHRENIA 6 0.0005
591 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
592 DELIRIUM 17 0.0005
593 DECUBITUS ULCER 4 0.0005
594 DYSPEPSIA 48 0.0005
595 METASTASES TO BONE 8 0.0005
596 ILEUS 6 0.0005
597 NEUTROPHIL COUNT INCREASED 5 0.0005
598 HYPERAESTHESIA 4 0.0005
599 NECK PAIN 27 0.0005
600 OSTEONECROSIS OF JAW 12 0.0005
601 SKIN EXFOLIATION 40 0.0005
602 NERVOUS SYSTEM DISORDER 15 0.0005
603 ALOPECIA 94 0.0005
604 SKIN FISSURES 9 0.0005
605 JOINT DISLOCATION 5 0.0005
606 THERAPY NON-RESPONDER 21 0.0005
607 MYDRIASIS 6 0.0005
608 RESPIRATORY DISORDER 14 0.0005
609 NASOPHARYNGITIS 86 0.0005
610 SKIN ULCER 12 0.0005
611 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
612 GASTROINTESTINAL DISORDER 41 0.0005
613 ASPERGILLUS INFECTION 3 0.0005
614 ANURIA 4 0.0005
615 MOBILITY DECREASED 33 0.0005
616 ANOREXIA 6 0.0005
617 PLATELET COUNT INCREASED 6 0.0005
618 PRESYNCOPE 11 0.0005
619 DRUG ERUPTION 8 0.0005
620 INTESTINAL OBSTRUCTION 17 0.0005
621 VIRAL INFECTION 15 0.0005
622 FOOT DEFORMITY 5 0.0005
623 LUNG INFILTRATION 4 0.0005
624 ERYTHEMA 92 0.0005
625 VAGINAL HAEMORRHAGE 19 0.0005
626 DEVICE EXPULSION 29 0.0005
627 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
628 ALANINE AMINOTRANSFERASE INCREASED 27 0.0004
629 ACUTE MYOCARDIAL INFARCTION 13 0.0004
630 SHOCK 10 0.0004
631 CYSTITIS 14 0.0004
632 SINUSITIS 45 0.0004
633 MYOCARDIAL ISCHAEMIA 5 0.0004
634 END STAGE RENAL DISEASE 8 0.0004
635 DEPRESSION 99 0.0004
636 HEPATIC FUNCTION ABNORMAL 16 0.0004
637 VASCULITIS 5 0.0004
638 POST PROCEDURAL HAEMORRHAGE 5 0.0004
639 HEPATIC ENZYME INCREASED 29 0.0004
640 MEMORY IMPAIRMENT 58 0.0004
641 LEUKOPENIA 21 0.0004
642 JOINT STIFFNESS 11 0.0004
643 PHARMACEUTICAL PRODUCT COMPLAINT 11 0.0004
644 HYPERLIPIDAEMIA 5 0.0004
645 DIVERTICULUM 3 0.0004
646 MEDICATION ERROR 23 0.0004
647 ORAL HERPES 8 0.0004
648 HYPOTHYROIDISM 13 0.0004
649 IMMUNODEFICIENCY 6 0.0004
650 WRONG TECHNIQUE IN DRUG USAGE PROCESS 15 0.0004
651 BLOOD BILIRUBIN INCREASED 11 0.0004
652 BODY TEMPERATURE DECREASED 4 0.0004
653 PYREXIA 139 0.0004
654 RASH PAPULAR 9 0.0004
655 HAEMODYNAMIC INSTABILITY 3 0.0004
656 ABDOMINAL PAIN 93 0.0004
657 ABDOMINAL PAIN UPPER 82 0.0004
658 HIP ARTHROPLASTY 6 0.0004
659 BONE MARROW FAILURE 8 0.0004
660 URINARY RETENTION 13 0.0004
661 HYPERBILIRUBINAEMIA 4 0.0004
662 ROTATOR CUFF SYNDROME 5 0.0004
663 HAEMOLYSIS 3 0.0004
664 INJECTION SITE DISCOMFORT 4 0.0004
665 OSTEOMYELITIS 7 0.0004
666 TACHYCARDIA 34 0.0004
667 HYPOTENSION 76 0.0004
668 EAR INFECTION 10 0.0004
669 RESPIRATORY FAILURE 27 0.0004
670 CONDITION AGGRAVATED 111 0.0004
671 DECREASED APPETITE 85 0.0004
672 LYMPHADENOPATHY 13 0.0004
673 PALLOR 10 0.0004
674 PHOTOSENSITIVITY REACTION 6 0.0004
675 OSTEOPOROSIS 15 0.0004
676 PAIN 223 0.0004
677 PLEURAL EFFUSION 22 0.0004
678 AMENORRHOEA 6 0.0004
679 PANCREATITIS ACUTE 8 0.0004
680 BREAST CANCER STAGE II 3 0.0004
681 PLATELET COUNT DECREASED 38 0.0004
682 CARPAL TUNNEL SYNDROME 5 0.0004
683 ABDOMINAL DISTENSION 37 0.0004
684 HYPONATRAEMIA 20 0.0004
685 COMPLICATION OF DEVICE REMOVAL 6 0.0004
686 MITRAL VALVE INCOMPETENCE 4 0.0004
687 MICTURITION URGENCY 4 0.0004
688 RASH PRURITIC 19 0.0004
689 ANAEMIA 67 0.0004
690 IMPAIRED QUALITY OF LIFE 5 0.0004
691 MYELODYSPLASTIC SYNDROME 5 0.0004
692 MUCOSAL INFLAMMATION 9 0.0003
693 APPLICATION SITE ERYTHEMA 9 0.0003
694 MULTI-ORGAN FAILURE 6 0.0003
695 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
696 LIVER DISORDER 15 0.0003
697 MUSCLE SPASMS 62 0.0003
698 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
699 BLOOD CREATININE INCREASED 22 0.0003
700 BRONCHITIS 25 0.0003
701 GASTROINTESTINAL INFECTION 3 0.0003
702 DISEASE RECURRENCE 16 0.0003
703 OEDEMA PERIPHERAL 41 0.0003
704 FREQUENT BOWEL MOVEMENTS 9 0.0003
705 PNEUMONIA 108 0.0003
706 HAEMOLYTIC ANAEMIA 3 0.0003
707 LEUKOCYTOSIS 6 0.0003
708 WHITE BLOOD CELL COUNT DECREASED 36 0.0003
709 PREMATURE BABY 10 0.0003
710 HYPERGLYCAEMIA 12 0.0003
711 WEIGHT INCREASED 73 0.0003
712 TINNITUS 15 0.0003
713 HYPERCALCAEMIA 4 0.0003
714 NO THERAPEUTIC RESPONSE 4 0.0003
715 CYST 4 0.0003
716 PNEUMONIA ASPIRATION 8 0.0003
717 COLITIS 12 0.0003
718 ARTERIOSCLEROSIS 3 0.0003
719 PARAESTHESIA 50 0.0003
720 MUSCULAR WEAKNESS 36 0.0003
721 ROAD TRAFFIC ACCIDENT 13 0.0003
722 NAUSEA 245 0.0003
723 RHINORRHOEA 20 0.0003
724 HAEMATOMA 8 0.0003
725 NODULE 4 0.0003
726 DYSMENORRHOEA 4 0.0003
727 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
728 OXYGEN SATURATION DECREASED 17 0.0003
729 DISABILITY 6 0.0003
730 MENSTRUATION IRREGULAR 8 0.0003
731 HAEMATOCRIT DECREASED 6 0.0003
732 RESTLESSNESS 11 0.0003
733 OVERDOSE 65 0.0003
734 BLOOD UREA INCREASED 5 0.0003
735 PREGNANCY 6 0.0003
736 EYELID PTOSIS 3 0.0003
737 CONTUSION 28 0.0003
738 DRUG EXPOSURE DURING PREGNANCY 10 0.0003
739 DRUG TOXICITY 4 0.0003
740 LOCALISED INFECTION 7 0.0003
741 NEURALGIA 7 0.0003
742 KNEE ARTHROPLASTY 6 0.0003
743 ORAL DISCOMFORT 4 0.0003
744 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
745 BLOOD PRESSURE DECREASED 19 0.0003
746 DYSPNOEA 162 0.0003
747 CARDIAC FAILURE 23 0.0003
748 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
749 SKIN DISCOLOURATION 13 0.0003
750 LOCAL SWELLING 5 0.0003
751 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
752 ASPIRATION 3 0.0003
753 CHOLELITHIASIS 9 0.0003
754 BIPOLAR DISORDER 3 0.0003
755 BLOOD GLUCOSE FLUCTUATION 3 0.0003
756 CHILLS 32 0.0003
757 FUNGAL INFECTION 9 0.0003
758 CARDIOMYOPATHY 4 0.0003
759 PANCYTOPENIA 15 0.0003
760 ARTHRALGIA 110 0.0003
761 BRADYCARDIA 14 0.0003
762 OSTEOPENIA 4 0.0003
763 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
764 ECONOMIC PROBLEM 4 0.0003
765 ASTHMA 29 0.0003
766 HYPERKALAEMIA 9 0.0003
767 ACUTE MYELOID LEUKAEMIA 4 0.0003
768 INSOMNIA 68 0.0003
769 CYANOSIS 4 0.0003
770 PRODUCTIVE COUGH 12 0.0003
771 METABOLIC ACIDOSIS 8 0.0003
772 CHOLECYSTITIS 3 0.0003
773 RESPIRATORY ARREST 7 0.0003
774 ULCER 4 0.0003
775 FEEDING DISORDER 5 0.0003
776 ACUTE KIDNEY INJURY 38 0.0003
777 INTERSTITIAL LUNG DISEASE 12 0.0003
778 GLOMERULAR FILTRATION RATE DECREASED 3 0.0003
779 ADVERSE DRUG REACTION 22 0.0002
780 PANCREATITIS 13 0.0002
781 AMNESIA 16 0.0002
782 FALL 81 0.0002
783 CHEST PAIN 45 0.0002
784 CARDIOMEGALY 3 0.0002
785 CARDIAC ARREST 20 0.0002
786 LIP SWELLING 8 0.0002
787 SKIN DISORDER 8 0.0002
788 EPISTAXIS 18 0.0002
789 DRUG INEFFECTIVE 313 0.0002
790 URINARY INCONTINENCE 7 0.0002
791 HAEMATEMESIS 6 0.0002
792 INFECTION 34 0.0002
793 RETCHING 5 0.0002
794 DIABETES MELLITUS 18 0.0002
795 HEMIPARESIS 4 0.0002
796 EATING DISORDER 5 0.0002
797 FOETAL EXPOSURE DURING PREGNANCY 19 0.0002
798 SCAR 4 0.0002
799 DYSPHAGIA 22 0.0002
800 RECTAL HAEMORRHAGE 10 0.0002
801 HEPATIC FAILURE 7 0.0002
802 METRORRHAGIA 4 0.0002
803 COMA 11 0.0002
804 ORTHOSTATIC HYPOTENSION 4 0.0002
805 DEAFNESS 6 0.0002
806 METASTASES TO LIVER 4 0.0002
807 ADVERSE EVENT 21 0.0002
808 PAIN IN EXTREMITY 67 0.0002
809 CONSTIPATION 49 0.0002
810 HERPES ZOSTER 13 0.0002
811 DIARRHOEA 143 0.0002
812 PNEUMONITIS 6 0.0002
813 LIMB INJURY 6 0.0002
814 HEADACHE 138 0.0002
815 DYSURIA 8 0.0002
816 RENAL FAILURE 29 0.0002
817 DEVICE OCCLUSION 3 0.0002
818 HALLUCINATION 16 0.0002
819 PROTEINURIA 4 0.0002
820 FEELING HOT 13 0.0002
821 DIZZINESS 105 0.0002
822 CARDIOGENIC SHOCK 3 0.0002
823 SYNCOPE 21 0.0002
824 HYPOACUSIS 9 0.0002
825 MUSCULOSKELETAL DISORDER 4 0.0002
826 ACUTE RESPIRATORY FAILURE 4 0.0002
827 CHRONIC KIDNEY DISEASE 16 0.0002
828 BLOOD PRESSURE FLUCTUATION 5 0.0002
829 ASTHENIA 78 0.0002
830 ANOSMIA 3 0.0002
831 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
832 DYSPHONIA 12 0.0002
833 OROPHARYNGEAL PAIN 19 0.0002
834 LABORATORY TEST ABNORMAL 6 0.0002
835 CEREBROVASCULAR ACCIDENT 34 0.0002
836 URINARY TRACT INFECTION 34 0.0002
837 THROMBOCYTOPENIA 22 0.0002
838 VERTIGO 12 0.0002
839 SKIN IRRITATION 9 0.0002
840 DEVICE ISSUE 17 0.0002
841 PERITONITIS 4 0.0002
842 SEDATION 5 0.0002
843 GAIT DISTURBANCE 36 0.0002
844 COUGH 52 0.0002
845 JAUNDICE 5 0.0002
846 CARDIAC FAILURE CONGESTIVE 15 0.0002
847 BLOOD POTASSIUM INCREASED 3 0.0002
848 HAEMOGLOBIN DECREASED 19 0.0002
849 SWELLING FACE 12 0.0002
850 TREATMENT NONCOMPLIANCE 10 0.0002
851 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
852 BACK PAIN 42 0.0002
853 COAGULOPATHY 3 0.0002
854 CYTOMEGALOVIRUS INFECTION 3 0.0002
855 FATIGUE 140 0.0002
856 MENTAL STATUS CHANGES 5 0.0002
857 LOSS OF CONSCIOUSNESS 23 0.0002
858 THROAT IRRITATION 8 0.0002
859 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
860 FLUID RETENTION 9 0.0002
861 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
862 BLOOD PRESSURE INCREASED 27 0.0002
863 RED BLOOD CELL COUNT DECREASED 5 0.0002
864 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
865 NASAL CONGESTION 10 0.0002
866 NEUTROPENIA 23 0.0002
867 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
868 PSYCHOTIC DISORDER 5 0.0002
869 GOUT 3 0.0002
870 APHASIA 5 0.0002
871 ARTHRITIS 13 0.0002
872 CRYING 6 0.0002
873 CEREBRAL INFARCTION 4 0.0002
874 BONE DISORDER 3 0.0002
875 HAEMORRHAGE 17 0.0002
876 AGRANULOCYTOSIS 3 0.0002
877 AGEUSIA 4 0.0002
878 HEAD INJURY 5 0.0002
879 WEIGHT DECREASED 44 0.0002
880 FEELING JITTERY 3 0.0002
881 BURNING SENSATION 11 0.0002
882 HIP FRACTURE 5 0.0002
883 HYPERHIDROSIS 20 0.0002
884 HAEMORRHOIDS 3 0.0002
885 GASTRITIS 4 0.0002
886 DEPRESSED MOOD 8 0.0002
887 BLOOD PRESSURE ABNORMAL 3 0.0002
888 DEVICE DIFFICULT TO USE 10 0.0002
889 OSTEONECROSIS 5 0.0002
890 AGITATION 11 0.0002
891 THROAT TIGHTNESS 4 0.0002
892 BODY TEMPERATURE INCREASED 3 0.0001
893 UNEVALUABLE EVENT 11 0.0001
894 NIGHTMARE 5 0.0001
895 DEMENTIA 4 0.0001
896 FEELING COLD 4 0.0001
897 HALLUCINATION, VISUAL 3 0.0001
898 BLOOD GLUCOSE INCREASED 27 0.0001
899 PAIN IN JAW 4 0.0001
900 ANGINA PECTORIS 4 0.0001
901 MYALGIA 23 0.0001
902 PULMONARY OEDEMA 6 0.0001
903 ATRIAL FIBRILLATION 13 0.0001
904 CHROMATURIA 3 0.0001
905 APPLICATION SITE PRURITUS 3 0.0001
906 CORONARY ARTERY DISEASE 4 0.0001
907 NO ADVERSE EVENT 23 0.0001
908 CHEST DISCOMFORT 13 0.0001
909 DEVICE BREAKAGE 5 0.0001
910 BALANCE DISORDER 11 0.0001
911 INTENTIONAL PRODUCT MISUSE 11 0.0001
912 ANXIETY 36 0.0001
913 SOMNOLENCE 25 0.0001
914 DYSKINESIA 5 0.0001
915 LUNG NEOPLASM MALIGNANT 5 0.0001
916 RHABDOMYOLYSIS 5 0.0001
917 DISEASE PROGRESSION 14 0.0001
918 HOSPITALISATION 18 0.0001
919 THERAPEUTIC RESPONSE DECREASED 7 0.0001
920 PSORIASIS 15 0.0001
921 SEIZURE 13 0.0001
922 ANHEDONIA 3 0.0001
923 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
924 ABNORMAL DREAMS 3 0.0001
925 FLUSHING 11 0.0001
926 RENAL IMPAIRMENT 9 0.0001
927 HAEMOPTYSIS 3 0.0001
928 DYSARTHRIA 4 0.0001
929 HOT FLUSH 8 0.0001
930 DEHYDRATION 14 0.0001
931 HEART RATE INCREASED 10 0.0001
932 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
933 FEMUR FRACTURE 3 0.0001
934 FEELING ABNORMAL 23 0.0001
935 NERVOUSNESS 5 0.0001
936 MENTAL DISORDER 4 0.0001
937 DRUG EFFECT DECREASED 5 0.0001
938 MYOCARDIAL INFARCTION 16 0.0001
939 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
940 COLITIS ULCERATIVE 4 0.0001
941 FLATULENCE 5 0.0001
942 DEATH 75 0.0001
943 SURGERY 5 0.0001
944 GASTRIC DISORDER 3 0.0001
945 RENAL DISORDER 4 0.0001
946 PALPITATIONS 10 0.0001
947 BONE PAIN 5 0.0001
948 CARDIAC DISORDER 8 0.0001
949 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
950 DRY SKIN 11 0.0001
951 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
952 IRRITABILITY 5 0.0001
953 BLOOD GLUCOSE DECREASED 4 0.0001
954 INJECTION SITE ERYTHEMA 10 0.0001
955 INFLUENZA 9 0.0001
956 DYSPNOEA EXERTIONAL 3 0.0001
957 ILLNESS 8 0.0001
958 ACNE 6 0.0001
959 DEEP VEIN THROMBOSIS 5 0.0001
960 SUICIDAL IDEATION 7 0.0001
961 SPEECH DISORDER 4 0.0001
962 DISORIENTATION 3 0.0001
963 THROMBOSIS 6 0.0001
964 EMOTIONAL DISTRESS 9 0.0001
965 DISTURBANCE IN ATTENTION 4 0.0001
966 TREMOR 12 0.0001
967 DEVICE LEAKAGE 3 0.0001
968 INJECTION SITE PAIN 21 0.0001
969 TOXICITY TO VARIOUS AGENTS 11 0.0001
970 COGNITIVE DISORDER 3 0.0001
971 ARRHYTHMIA 3 0.0001
972 PROSTATE CANCER 5 0.0001
973 INFLUENZA LIKE ILLNESS 5 0.0001
974 DERMATITIS ATOPIC 3 0.0001
975 PRODUCT DOSE OMISSION ISSUE 17 0.0001
976 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
977 INCORRECT DOSE ADMINISTERED 13 0.0001
978 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
979 COVID-19 10 0.0001
980 HAEMATOCHEZIA 3 0.0001
981 INJECTION SITE SWELLING 4 0.0001
982 DRUG DEPENDENCE 8 0.0000
983 PRODUCT STORAGE ERROR 4 0.0000
984 DEVICE MALFUNCTION 3 0.0000
985 DRUG INTERACTION 7 0.0000
986 BREAST CANCER 4 0.0000
987 NEUROPATHY PERIPHERAL 4 0.0000
988 PULMONARY EMBOLISM 4 0.0000
989 DYSGEUSIA 3 0.0000
990 DRUG DOSE OMISSION 6 0.0000